| 000 | 01651 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516154641.0 | ||
| 264 | 0 | _c20130829 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2013.12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiacomini, K M | |
| 245 | 0 | 0 |
_aInternational Transporter Consortium commentary on clinically important transporter polymorphisms. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJul 2013 |
||
| 300 |
_a23-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily G, Member 2 |
| 650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xgenetics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aGene Frequency _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLiver-Specific Organic Anion Transporter 1 |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aOrganic Anion Transporters _xgenetics |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 700 | 1 | _aBalimane, P V | |
| 700 | 1 | _aCho, S K | |
| 700 | 1 | _aEadon, M | |
| 700 | 1 | _aEdeki, T | |
| 700 | 1 | _aHillgren, K M | |
| 700 | 1 | _aHuang, S-M | |
| 700 | 1 | _aSugiyama, Y | |
| 700 | 1 | _aWeitz, D | |
| 700 | 1 | _aWen, Y | |
| 700 | 1 | _aXia, C Q | |
| 700 | 1 | _aYee, S W | |
| 700 | 1 | _aZimdahl, H | |
| 700 | 1 | _aNiemi, M | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 94 _gno. 1 _gp. 23-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2013.12 _zAvailable from publisher's website |
| 999 |
_c22847505 _d22847505 |
||